Kiromic BioPharma, Inc.

KRBP · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$27-$21-$35-$26
Dep. & Amort.$2$2$2$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$0$1$4
Change in WC$0-$3$4$1
Other Non-Cash$4$1$4$0
Operating Cash Flow-$19-$21-$24-$20
Investing Activities
PP&E Inv.-$0-$0-$5-$2
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0-$0
Investing Cash Flow-$0-$0-$5-$2
Financing Activities
Debt Repay.$0$23$4$0
Stock Issued$0$1$0$40
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$18-$0-$0-$3
Financing Cash Flow$18$24$4$37
Forex Effect$0$0$0$0
Net Chg. in Cash-$1$3-$25$15
Supplemental Information
Beg. Cash$3$1$25$10
End Cash$2$3$1$25
Free Cash Flow-$20-$21-$29-$22
Kiromic BioPharma, Inc. (KRBP) Financial Statements & Key Stats | AlphaPilot